Platinum-refractory ovarian cancer

Treatment Patterns and Health Outcomes in Platinum-Refractory or Platinum-Resistant Ovarian Cancer: A Retrospective Medical Record Review
Rohan Parikh, Samantha K. Kurosky, Margarita Udall, Jane Chang, Joseph C. Cappelleri, Jim P. Doherty, James A. Kaye

International Journal of Gynecologic Cancer May 2018, 28 (4) 738-748; DOI: 10.1097/IGC.0000000000001222
Phase II study of irinotecan plus doxorubicin for early recurrent or platinum-refractory ovarian cancer: interim analysis
S. Nishimura, H. Tsuda, Y. Hashiguchi, K. Kokawa, R. Nishimura, O. Ishiko, S. Kamiura, K. Hasegawa, N. Umesaki

International Journal of Gynecologic Cancer Jan 2007, 17 (1) 159-163; DOI: 10.1111/j.1525-1438.2006.00728.x

Main menu